3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514414, 546201, 548492, C07D 4006, C07D40306, A61K 3140, A61K 31445

Patent

active

053247370

ABSTRACT:
2-R.sub.2 -R.sub.4 -substitutea-3-R.sub.3 -CO-1-[(C-attached-N-heteryl)(Alk).sub.n ]-1H-indoles useful as analgesic, anti-rheumatic, anti-inflammatory or anti-glaucoma agents.

REFERENCES:
patent: 3489770 (1970-01-01), Herbst
patent: 3946029 (1976-03-01), Descamps et al.
patent: 4634776 (1987-01-01), Bell
Inion et al., Europ. J. of Med. Chem., 10(3), 276-285 (1975).
Tambute, Acad. Sci. Comp. Rend., Ser. C 278(20), 1239-1242 (1974).
Dalla Croce, Chem. Abst., 80, 95655f (1974).
Bosch et al., Tetrahedron, 40(8), 1419-24 (1984).
Bosch et al., J. Org. Chem., 48(25), 4836-41 (1983).
Bennasar et al., Tetrahedron, 42(2), 637-647 (1986).
Vartangan et al., Ann. Khim. Zh., 38(5), 308-313 (1985); Chem. Abst. 105, 114874e (1985).
Nilsson et al., Acta. Chem. Scand., Ser. B, B39(7), 531-537 (1985).
Sasakura et al., Syn. Comm. 18(3), 265-273 (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2377631

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.